Dược phẩm Imexpharm (IMP) in the Dược phẩm sector, listed on HOSE, recorded an unusual volume event on May 13, 2026. The stock traded 71.9K shares — 3.1x its 20-day average of 23.3K shares. The stock closed at 47,700 VND, gaining 1.81% on the day. Intraday, shares ranged from 47,000 to 49,850 VND after opening at 47,000 VND, reflecting active two-sided trading throughout the session.
A 3.1x spike relative to the 20-day average is a notable departure from normal trading patterns that warrants attention. Volume spikes on Vietnamese equities are frequently associated with corporate announcements, regulatory decisions, earnings releases, or shifts in foreign investor positioning. On days with no identifiable news catalyst, unusual volume can reflect block trades, index rebalancing activity, or early positioning ahead of a forthcoming disclosure.
On May 13, 2026, 3 news articles related to IMP appeared in Vietnamese financial media. The highest-impact story reported: Imexpharm (IMP) leaders sold shares after Chinese pharmaceutical giant Livzon Group acquired a 67.87% stake via Lian SGP Holding for nearly 6,000 billion VND (~$240M), taking control from SK Group. A second article noted: Multiple Imexpharm leaders sold IMP shares on May 7, while Lian SGP Holding Pte. Ltd. Investors should assess whether the news represents a fundamental change in the company's outlook or a short-term sentiment shift.
For investors tracking IMP, a volume spike of this magnitude (3.1x) should be cross-referenced against the company's upcoming earnings calendar, any pending regulatory filings, and broader sector momentum. Historical volume spikes on Vietnamese equities that are accompanied by price gains of more than 2% and sustained over the following three sessions have often preceded formal corporate disclosures. Where the volume spike occurs without a corresponding price move, it may reflect distribution rather than accumulation. Use the links below to review IMP's full price history and recent news coverage.
Analysis generated by Aveluro Research Desk from market data. Not investment advice. Methodology
Information provided for educational purposes only. Past performance does not guarantee future results. Data sourced from public Vietnamese market feeds.
Last updated: 2026-05-13T17:53:57Z.